Wang Guoyi, Yi Qiong, Zhang Xueqin, Zhou Min, Zhao Jinwen, Lu Haiyuan, Li Ju, Meng Deqian, Xu Yong, Wang Kai
Department of Nephrology, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China.
Department of Rehabilitation, The Affiliated Huaian No.1 People's Hospital of Nanjing Medical University, Huaian, China.
Front Nutr. 2025 Jul 28;12:1596836. doi: 10.3389/fnut.2025.1596836. eCollection 2025.
While plant protein has been suggested to offer renoprotective benefits, the optimal proportion of dietary plant protein and its relationship with outcomes across different stages of chronic kidney disease (CKD) remains unclear.
Using data from the National Health and Nutrition Examination Survey (NHANES), we examined the association between plant protein ratio and estimated glomerular filtration rate (eGFR) across CKD stages. Plant protein ratio was categorized as low (< 33%), medium (33%-66%), and high (≥ 66%). Multiple imputation was performed for missing data. Weighted linear regression models were used to analyze plant protein ratio-eGFR associations, while Cox proportional hazards models assessed mortality risk. Dose-response relationships were evaluated using restricted cubic splines.
Among 16,163 participants, distinct patterns emerged across CKD stages. In Non-CKD, high plant protein ratio was associated with significantly higher eGFR compared to low plant protein ratio (β = 0.790, = 0.039). In CKD G4, medium plant protein ratio showed significantly higher eGFR (β = 1.791, = 0.025) compared to low plant protein ratio. For mortality risk, CKD G3 patients with medium plant protein ratio demonstrated significantly lower risk (HR = 0.67, 95% CI: 0.44-1.00, = 0.047) compared to low plant protein ratio. Dose-response analyses revealed stage-specific patterns: U-shaped relationships in early CKD, transitioning to inverted U-shaped and J-shaped patterns in advanced stages.
The association between plant protein ratio and outcomes varies across CKD stages, suggesting the need for stage-specific dietary recommendations. While moderate plant protein intake might be beneficial in early CKD, our findings in advanced stages were largely non-significant and require confirmation in larger studies before clinical recommendations can be made. These findings support a more nuanced approach to dietary protein source management in CKD, though further prospective studies are needed to confirm these associations.
虽然已有研究表明植物蛋白具有肾脏保护作用,但饮食中植物蛋白的最佳比例及其与慢性肾脏病(CKD)不同阶段结局的关系仍不明确。
利用美国国家健康与营养检查调查(NHANES)的数据,我们研究了CKD各阶段植物蛋白比例与估计肾小球滤过率(eGFR)之间的关联。植物蛋白比例分为低(<33%)、中(33%-66%)和高(≥66%)。对缺失数据进行多重插补。采用加权线性回归模型分析植物蛋白比例与eGFR的关联,同时使用Cox比例风险模型评估死亡风险。使用受限立方样条评估剂量反应关系。
在16163名参与者中,CKD各阶段呈现出不同的模式。在非CKD阶段,与低植物蛋白比例相比,高植物蛋白比例与显著更高的eGFR相关(β = 0.790,P = 0.039)。在CKD G4阶段,与低植物蛋白比例相比,中等植物蛋白比例的eGFR显著更高(β = 1.791,P = 0.025)。对于死亡风险,与低植物蛋白比例相比,CKD G3阶段中等植物蛋白比例的患者死亡风险显著更低(HR = 0.67,95%CI:0.44-1.00,P = 0.047)。剂量反应分析揭示了特定阶段的模式:CKD早期呈U形关系,晚期转变为倒U形和J形模式。
植物蛋白比例与结局的关联在CKD各阶段有所不同,这表明需要针对特定阶段的饮食建议。虽然适度摄入植物蛋白在CKD早期可能有益,但我们在晚期阶段的研究结果大多无统计学意义,在能够做出临床建议之前,需要在更大规模的研究中加以证实。这些发现支持在CKD中采用更细致入微的方法来管理饮食蛋白来源,不过还需要进一步的前瞻性研究来证实这些关联。